Right-sided MSLN-positive colon cancer patients had a significantly poorer prognosis (P < 0.0001); likewise, among the left-sided colon cancer patients, the MSLN-positive group tended to exhibit a poorer prognosis (P = 0.056). The gene discussed is MSLN; the disease is malignant colon neoplasm.